Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Blood (2021) 137 (19): 2646–2656.

https://doi.org/10.1182/blood.2020008825

Published: 2021

Includes: Supplemental data

Journal Articles

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Kristina Hoelig, MD, Helmuth Schmidt, MD, Gero Hütter, MD, Michael Kramer, Raphael Teipel, MD, Kristin Zimmer, MD, Matthias Blechschmidt, MD, Tigran Torosian, MD, Rainer Ordemann, MD, Frank Kroschinsky, MD, Alexander H. Schmidt, MD PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3369.

https://doi.org/10.1182/blood.V128.22.3369.3369

Published: 2016

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Andreas Hüttmann, MD, Stefan P Müller, MD, Jan Rekowski, Dipl.-Stat., Bernd Hertenstein, MD, Christiane Franzius, MD, Anke Franzke, MD, Frank M Bengel, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Paul La Rosée, MD, Martin Freesmeyer, MD, Heinz-Gert Hoeffkes, MD, Andreas Hertel, MD, Dirk Behringer, Rolf Mesters, MD, Matthias Weckesser, MD, Stefan Mahlmann, MD, Uwe Haberkorn, MD, Uwe Martens, MD, Gabriele Prange-Krex, MD, Agnieszka Korfel, MD, Winfried Brenner, MD, Aristoteles Giagounidis, Regina Moeller, MD, Volker Runde, MD, Matthias Sandmann, MD, Hubertus Hautzel, MD, Stefan Wilop, MD, Thomas Krohn, MD, Heinz Dürk, MD, Dirk Strumberg, MD, Michael Heike, MD, Claudia Ose, Marcus Brinkmann, Guido Trenn, MD, Otto Kloke, MD, Christiane Kreisel-Büstgens, MD, Tu-Anh Dang, MD, Gerhard Heil, Karl-Heinz Jöckel, PhD, Dieter Hoelzer, MD, Wolfram Klapper, MD, Ulrich Duehrsen, MD

Blood (2016) 128 (22): 185.

https://doi.org/10.1182/blood.V128.22.185.185

Published: 2016

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Ulrich Duehrsen, MD, Stefan P Müller, MD, Jan Rekowski, Dipl.-Stat., Bernd Hertenstein, MD, Christiane Franzius, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Anke Franzke, MD, Frank M Bengel, MD, Paul La Rosée, MD, Martin Freesmeyer, MD, Heinz-Gert Hoeffkes, MD, Andreas Hertel, MD, Dirk Behringer, Gabriele Prange-Krex, MD, Martin Griesshammer, MD, Jens Holzinger, MD, Stefan Wilop, MD, Thomas Krohn, MD, Aruna Raghavachar, MD, Georg Maschmeyer, MD, Ingo Brink, MD, Roland Schroers, MD, Tobias Gaska, MD, Tu-Anh Dang, MD, Aristoteles Giagounidis, Ariane Dienst, MD, Hubertus Hautzel, MD, Ralph Naumann, MD, Alfred Klein, MD, Dennis Hahn, MD, Gabriele Pöpperl, MD, Matthias Grube, MD, Jörg Marienhagen, MD, Andreas Schwarzer, MD, Lars Kurch, MD, Thomas Höhler, MD, Heike Steiniger, MD, Holger Nückel, MD, Thomas Südhoff, MD, Wolfgang Römer, MD, Marcus Brinkmann, Claudia Ose, Dieter Hoelzer, MD, Jan Dürig, MD, Karl-Heinz Jöckel, PhD, Wolfram Klapper, MD, Andreas Hüttmann, MD

Blood (2016) 128 (22): 1857.

https://doi.org/10.1182/blood.V128.22.1857.1857

Published: 2016

Journal Articles

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Patricia Johansson, MD, Jan Dürig, MD, Jan Rekowski, Dipl.-Stat., Stefan P Müller, MD, Bernd Hertenstein, MD, Christiane Franzius, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Paul La Rosée, Prof. Dr. MD, Martin Freesmeyer, MD, Stefan Wilop, MD, Thomas Krohn, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD

Blood (2015) 126 (23): 3880.

https://doi.org/10.1182/blood.V126.23.3880.3880

Published: 2015

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Blood (2014) 124 (21): 391.

https://doi.org/10.1182/blood.V124.21.391.391

Published: 2014

Journal Articles

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Esa Jantunen, Ariane Boumendil, Herve Finel, Jian-Jian Luan, Peter Johnson, Alessandro Rambaldi, Andrew Haynes, Michel A. Duchosal, Wolfgang Bethge, Pierre Biron, Kristina Carlson, Charles Craddock, Claudius Rudin, Jurgen Finke, Gilles Salles, Frank Kroschinsky, Anna Sureda, Peter Dreger

Blood (2013) 121 (13): 2529–2532.

https://doi.org/10.1182/blood-2012-11-466839

Published: 2013

Includes: Supplemental data

Journal Articles

Focal Positivity for Non-Specific Esterase in AML: A Surrogate Marker to Predict AML with t(8;21)/ RUNX1-RUNX1T1

Stefani Parmentier, MD, Nicole Birninger, Uta Oelschlägel, Brigitte Mohr, Markus Schaich, MD, Frank Kroschinsky, MD, Christian Thiede, MD, Gerhard Ehninger, MD

Blood (2011) 118 (21): 2534.

https://doi.org/10.1182/blood.V118.21.2534.2534

Published: 2011

Journal Articles

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Katrin Wetzko, MD, Matthias Blechschmidt, MD, Kristina Hölig, MD, Kirsten Poppe-Thiede, MD, Susanne Ganepola, MD, Roman Fischbach, MD, Rainer Ordemann, MD, Michael Laniado, MD, Bernhard Schulte-Hubbert, MD, Markus Schuler, MD, Livia Cotta, MD, Dietrich Braumann, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD

Blood (2011) 118 (21): 4057.

https://doi.org/10.1182/blood.V118.21.4057.4057

Published: 2011

Journal Articles

Dysmyelopoiesis In Healthy Bone Marrow Donors

Stefani Parmentier, MD, Kerstin Lorenz, Michael Kramer, Ulrich Schuler, MD, Rainer Ordemann, MD, Johannes Schetelig, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD

Blood (2010) 116 (21): 4006.

https://doi.org/10.1182/blood.V116.21.4006.4006

Published: 2010

Journal Articles

Interleukin-10 Promoter Polymorphisms Associating with Severe Acute Graft-Versus-Host Disease In HLA-Identical Sibling Transplants.

Nadja Gruner, Christian Thiede, Martin Wermke, Gerhard Ehninger, Martin Bornhauser, Frank Kroschinsky

Blood (2010) 116 (21): 4533.

https://doi.org/10.1182/blood.V116.21.4533.4533

Published: 2010

Journal Articles

A variant allele of Growth Factor Independence 1 ( GFI1 ) is associated with acute myeloid leukemia

Blood (2010) 115 (12): 2462–2472.

https://doi.org/10.1182/blood-2009-08-239822

Published: 2010

Journal Articles

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas (PETAL trial): Correlation between Clinical Variables and PET Parameters.

Andreas Hüttmann, MD, Stefan Müller, MD, Andreas Bockisch, MD, PhD, Rolf Mesters, MD, Frank Kroschinsky, MD, Gabriele Prange-Krex, MD, Henrike Thomssen, MD, Aristoteles Giagounidis, MD, Ulrich Duehrsen, MD

Blood (2009) 114 (22): 2695.

https://doi.org/10.1182/blood.V114.22.2695.2695

Published: 2009

Journal Articles

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors

Kristina Hölig, Michael Kramer, Frank Kroschinsky, Martin Bornhäuser, Thilo Mengling, Alexander H. Schmidt, Claudia Rutt, Gerhard Ehninger

Blood (2009) 114 (18): 3757–3763.

https://doi.org/10.1182/blood-2009-04-218651

Published: 2009

Journal Articles

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

Mathias Hanel, Kai Friedrichsen, Frank Kroschinsky, Wolfram Poenisch, Kerstin Schaefer-Eckart, Walter Aulitzky, Norma Peter, Sascha Neugebauer, Regina Herbst, Annette Hanel, Martin Wilhelm, Dietger Niederwieser, Gerhard Ehninger, Friedrich Fiedler

Blood (2008) 112 (11): 2972.

https://doi.org/10.1182/blood.V112.11.2972.2972

Published: 2008

Journal Articles

Predictors for the Efficacy of Peripheral Blood Progenitor Cell (PBPC) Collection–Results from 4050 Harvests Performed in a Single Centre

Kristina Hoelig, Frank Kroschinsky, Michael Kramer, Matthias Blechschmidt, Kristin Zimmer, Uta Oelschlaegel, Claudia Rutt, Martin Bornhaeuser, Gerhard Ehninger

Blood (2008) 112 (11): 4131.

https://doi.org/10.1182/blood.V112.11.4131.4131

Published: 2008

Journal Articles

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Uta Oelschlaegel, PhD, Sina Koch, PhD, Markus Schaich, MD, Frank Kroschinsky, MD, Stefani Parmentier, MD, Gerhard Ehninger, MD, Christian Thiede, MD

Blood (2008) 112 (11): 1490.

https://doi.org/10.1182/blood.V112.11.1490.1490

Published: 2008

Journal Articles

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Blood (2008) 112 (11): 3600.

https://doi.org/10.1182/blood.V112.11.3600.3600

Published: 2008

Journal Articles

Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients

Blood (2008) 112 (11): 3602.

https://doi.org/10.1182/blood.V112.11.3602.3602

Published: 2008

Journal Articles

MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients

Hannes Wandt, Ulrike Schäkel, Frank Kroschinsky, Gabriele Prange-Krex, Brigitte Mohr, Christian Thiede, Ulrich Pascheberg, Silke Soucek, Markus Schaich, Gerhard Ehninger

Blood (2008) 111 (4): 1855–1861.

https://doi.org/10.1182/blood-2007-08-101162

Published: 2008

NARROW

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Focal Positivity for Non-Specific Esterase in AML: A Surrogate Marker to Predict AML with t(8;21)/ RUNX1-RUNX1T1

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Dysmyelopoiesis In Healthy Bone Marrow Donors

Interleukin-10 Promoter Polymorphisms Associating with Severe Acute Graft-Versus-Host Disease In HLA-Identical Sibling Transplants.

A variant allele of Growth Factor Independence 1 ( GFI1 ) is associated with acute myeloid leukemia

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas (PETAL trial): Correlation between Clinical Variables and PET Parameters.

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors

Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)

Predictors for the Efficacy of Peripheral Blood Progenitor Cell (PBPC) Collection–Results from 4050 Harvests Performed in a Single Centre

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients

MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only